REVANCE THERAPEUTICS INC

CUSIP: 761330109 Class: Common Stock

Yarbrough Capital, LLC's Holding History (CIK: 0001767686)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 12,203 Value ($000) $37 Avg Close — Range —
Q3 2024
Shares 12,203 Value ($000) $63 Avg Close — Range —
Q2 2024
Shares 12,203 Value ($000) $31 Avg Close — Range —
Q1 2024
Shares 12,203 Value ($000) $60 Avg Close — Range —
Q4 2023
Shares 12,203 Value ($000) $107 Avg Close — Range —
Q3 2023
Shares 12,203 Value ($000) $140 Avg Close — Range —
Q2 2023
Shares 12,203 Value ($000) $309 Avg Close — Range —
Q1 2023
Shares 12,203 Value ($000) $393 Avg Close — Range —